CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Meilleure Health Intrntnl Indu Grp Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Meilleure Health Intrntnl Indu Grp Ltd
Unit 2906, Tower 1, Lippo Centre
89 Queensway
Phone: +852 25631500p:+852 25631500 Hong Kong Ticker: 23272327
Business Summary
Meilleure Health International Industry Group Ltd is an investment holding company mainly engaged in the production and sale of cannabis health products. The Company operates through four segments. The Healthcare-Related Business segment is engaged in health management services, medical beauty services, and sales of health-related products and Cannabidiol (CBD) downstream products. The Property-Related Business segment is engaged in real estate sales agency, investment property leasing, and residential property development and sales. The Trading Business segment is engaged in the trading of building materials and new energy products, the provision of new energy product procurement services, and health-related product sales agency services. The Equity Investment Business segment is engaged in the management of investment portfolio.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2844 Perfumes, cosmetics, and other toilet preparations
8062 General medical and surgical hospitals
7231 Beauty shops
6512 Operators of nonresidential buildings
5039 Construction materials, not elsewhere classified
6531 Real estate agents and managers
1531 Operative builders
6282 Investment advice
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Co-Chairman of the Board WentaoZeng 58 5/27/2019 10/18/2017
Executive Co-Chairman of the Board XuzhouZhou 66 5/27/2019 8/30/2013
Executive Vice Chairman of the Board, Chief Executive Officer Wen ChuanZhou 38 9/23/2013 8/30/2013
5 additional Officers and Directors records available in full report.

Business Names
Business Name
2327
Jiwa Bio-Pharm Holdings Limited

General Information
Number of Employees: 46 (As of 12/31/2024)
Outstanding Shares: 4,092,562,636 (As of 12/31/2024)
Stock Exchange: HKG
Fax Number: +852 25631900


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, June 28, 2025